help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-1585
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Schreckenberg, R.
Right arrow Articles by Schlüter, K.-D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schreckenberg, R.
Right arrow Articles by Schlüter, K.-D.
Endocrinology Vol. 150, No. 8 3735-3741
Copyright © 2009 by The Endocrine Society

Cell-Specific Effects of Nitric Oxide Deficiency on Parathyroid Hormone-Related Peptide (PTHrP) Responsiveness and PTH1 Receptor Expression in Cardiovascular Cells

Rolf Schreckenberg, Sibylle Wenzel, Rui Manuel da Costa Rebelo, Anja Röthig, Rainer Meyer and Klaus-Dieter Schlüter

Physiologisches Institut (R.S., S.W., R.M.d.C.R., A.R., K.-D.S.), Justus-Liebig-Universität Giessen, D-35392 Giessen, Germany; and Institut für Physiologie II (R.M.), Universitätsklinikum Bonn, D-53111 Bonn, Germany

Address all correspondence and requests for reprints to: Dr. Rolf Schreckenberg, Physiologisches Institut, Aulweg 129, D-35392 Giessen, Germany. E-mail: rolf.schreckenberg{at}ugcvr.de.

The missing influence of estrogen on endothelial nitric oxide (NO) synthase often forms the basis for a worsening of the cardiac risk profile for women in postmenopause. Various studies have shown that decreasing estrogen levels also directly effect the expression of PTHrP and TGFβ1. PTHrP is involved in the endothelium-dependent regulation of coronary resistance and cardiac function. The current study investigates to what extent chronic NO deficit affects the cardiac effects of PTHrP. NO deficit was achieved in female adult rats by feeding them the NO synthase inhibitor N-omega-nitro-L-arginine methyl ester over a period of 4 wk. Isolated hearts of the conditioned animals were investigated in Langendorff technique and perfused for 3 min with 100 nM PTHrP. The contraction behavior of isolated cardiomyocytes was registered in a cell-edge detection system. Hearts from untreated animals displayed a significant drop in left ventricular developed pressure and a pronounced increase in heart rate in consequence of short term PTHrP stimulation. In hearts from NO-deficient rats PTHrP no longer affected the inotropy and chronotropy. The vasodilating effect of PTHrP on coronary vessels was, however, independent of the NO level. These changes were accompanied by a differing expression of the PTH1 receptor. TGFβ1 was identified as an important mediator for the regulation of the PTH1 receptor in myocytic but not endothelial cells. These results indicate that chronic NO deficit down-regulates the PTH1 receptor in a TGFβ1-dependent way. These findings are important with respect to the relatively new therapy of postmenopausal osteoporosis with PTHrP analogs.




This article has been cited by other articles:


Home page
EndocrinologyHome page
J. Iqbal and M. Zaidi
Understanding Estrogen Action during Menopause
Endocrinology, August 1, 2009; 150(8): 3443 - 3445.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society